Sponsor or institution
Clinical trials and research at Viewpoint Molecular Targeting, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Antibody-based targeted alpha therapy for ovarian cancer
A new antibody-guided treatment using alpha radiation is being developed for women with metastatic high-grade serous ovarian cancer to improve outcomes after standard therapies.
-
Targeted therapy using alpha particles for ovarian cancer treatment
This study is testing a new way to treat high-grade serous ovarian cancer by using a special type of radiation that targets cancer cells directly, hoping to help patients who haven't had success with other treatments feel better and live longer.
-
Targeting neuroblastoma with advanced alpha particle therapy.
This study is testing a new way to treat neuroblastoma, a common childhood cancer, by using a special therapy that targets cancer cells while trying to keep healthy cells safe, and it's being done in mice that have a similar type of cancer to help make sure it's safe and effective for kids.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.